{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1142.23","meta":{"versionId":"12","lastUpdated":"2016-09-09T01:00:03.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.23","version":"20160909","name":"C2S HIV/AIDS Information Sensitivity","status":"active","date":"2016-09-09T01:00:03-04:00","publisher":"SAMHSA Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","concept":[{"code":"0575F","display":"Hiv rna control plan of care, documented (hiv)"},{"code":"3292F","display":"Hiv testing ordered or documented and reviewed during the first or second prenatal visit (pre-cr)"},{"code":"3490F","display":"History of aids-defining condition (hiv)"},{"code":"3491F","display":"Hiv indeterminate (infants of undetermined hiv status born of hiv-infected mothers) (hiv)"},{"code":"3492F","display":"History of nadir cd4+ cell count \u003c350 cells/mm (hiv)"},{"code":"3493F","display":"No history of nadir cd4+ cell count \u003c350 cells/mmand no history of aids-defining condition (hiv)"},{"code":"3494F","display":"Cd4+ cell count \u003c200 cells/mm (hiv)"},{"code":"3495F","display":"Cd4+ cell count 200 - 499 cells/mm (hiv)"},{"code":"3496F","display":"Cd4+ cell count \u003d500 cells/mm (hiv)"},{"code":"3497F","display":"Cd4+ cell percentage \u003c15% (hiv)"},{"code":"3498F","display":"Cd4+ cell percentage \u003e/\u003d15% (hiv)"},{"code":"3500F","display":"Cd4+ cell count or cd4+ cell percentage documented as performed (hiv)"},{"code":"3502F","display":"Hiv rna viral load below limits of quantification (hiv)"},{"code":"3503F","display":"Hiv rna viral load not below limits of quantification (hiv)"},{"code":"3510F","display":"Documentation that tuberculosis (tb) screening test performed and results interpreted (hiv) (ibd)"},{"code":"3511F","display":"Chlamydia and gonorrhea screenings documented as performed (hiv)"},{"code":"3512F","display":"Syphilis screening documented as performed (hiv)"},{"code":"3513F","display":"Hepatitis b screening documented as performed (hiv)"},{"code":"3514F","display":"Hepatitis c screening documented as performed (hiv)"},{"code":"3515F","display":"Patient has documented immunity to hepatitis c (hiv)"},{"code":"4149F","display":"Hepatitis b vaccine injection administered or previously received (hep-c, hiv) (ibd)"},{"code":"4270F","display":"Patient receiving potent antiretroviral therapy for 6 months or longer (hiv)"},{"code":"4271F","display":"Patient receiving potent antiretroviral therapy for less than 6 months or not receiving potent antiretroviral therapy (hiv)"},{"code":"4274F","display":"Influenza immunization administered or previously received (hiv) (p-esrd)"},{"code":"4276F","display":"Potent antiretroviral therapy prescribed (hiv)"},{"code":"4279F","display":"Pneumocystis jiroveci pneumonia prophylaxis prescribed (hiv)"},{"code":"4280F","display":"Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count or percentage (hiv)"},{"code":"4290F","display":"Patient screened for injection drug use (hiv)"},{"code":"4293F","display":"Patient screened for high-risk sexual behavior (hiv)"},{"code":"86689","display":"Confirmation test for antibody to Human T-cell lymphotropic virus (HTLV) or HIV"},{"code":"86701","display":"Analysis for antibody to HIV -1 virus"},{"code":"86702","display":"Analysis for antibody to HIV-2 virus"},{"code":"86703","display":"Analysis for antibody to HIV-1 and HIV-2 virus"},{"code":"87389","display":"Detection test for HIV-1 and HIV-2"},{"code":"87390","display":"Detection test for HIV-1"},{"code":"87391","display":"Detection test for HIV-2"},{"code":"87534","display":"Detection test for HIV-1 virus"},{"code":"87535","display":"Detection test for HIV-1 virus"},{"code":"87536","display":"Detection test for HIV-1 virus"},{"code":"87537","display":"Detection test for HIV-2 virus"},{"code":"87538","display":"Detection test for HIV-2 virus"},{"code":"87539","display":"Detection test for HIV-2 virus"},{"code":"87900","display":"Infectious agent drug susceptibility analysis"},{"code":"87901","display":"Analysis test for HIV-1 virus"},{"code":"87903","display":"Analysis test for HIV-1 virus"},{"code":"87904","display":"Analysis test for HIV-1 virus"},{"code":"87906","display":"Analysis test for HIV-1 virus"},{"code":"G0432","display":"Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening"},{"code":"G0433","display":"Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening"},{"code":"G0435","display":"Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening"},{"code":"G8491","display":"I intend to report the hiv/aids measures group"},{"code":"G8500","display":"All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient"},{"code":"S3645","display":"Hiv-1 antibody testing of oral mucosal transudate"}]}]},"expansion":{"identifier":"urn:uuid:72714ab8-e91e-4890-a673-a4a923cccbc3","timestamp":"2022-06-10T05:16:38-04:00","total":51,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"0575F","display":"Hiv rna control plan of care, documented (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3292F","display":"Hiv testing ordered or documented and reviewed during the first or second prenatal visit (pre-cr)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3490F","display":"History of aids-defining condition (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3491F","display":"Hiv indeterminate (infants of undetermined hiv status born of hiv-infected mothers) (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3492F","display":"History of nadir cd4+ cell count \u003c350 cells/mm (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3493F","display":"No history of nadir cd4+ cell count \u003c350 cells/mmand no history of aids-defining condition (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3494F","display":"Cd4+ cell count \u003c200 cells/mm3 (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3495F","display":"Cd4+ cell count 200 - 499 cells/mm3 (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3496F","display":"Cd4+ cell count \u003e\u003d500 cells/mm3 (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3497F","display":"Cd4+ cell percentage \u003c15% (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3498F","display":"Cd4+ cell percentage \u003e/\u003d15% (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3500F","display":"Cd4+ cell count or cd4+ cell percentage documented as performed (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3502F","display":"Hiv rna viral load below limits of quantification (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3503F","display":"Hiv rna viral load not below limits of quantification (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3510F","display":"Documentation that tuberculosis (tb) screening test performed and results interpreted (hiv) (ibd)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3511F","display":"Chlamydia and gonorrhea screenings documented as performed (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3512F","display":"Syphilis screening documented as performed (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3513F","display":"Hepatitis b screening documented as performed (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3514F","display":"Hepatitis c screening documented as performed (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"3515F","display":"Patient has documented immunity to hepatitis c (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"4149F","display":"Hepatitis b vaccine injection administered or previously received (hep-c, hiv) (ibd)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"4270F","display":"Patient receiving potent antiretroviral therapy for 6 months or longer (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"4271F","display":"Patient receiving potent antiretroviral therapy for less than 6 months or not receiving potent antiretroviral therapy (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"4274F","display":"Influenza immunization administered or previously received (hiv) (p-esrd)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"4276F","display":"Potent antiretroviral therapy prescribed (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"4279F","display":"Pneumocystis jiroveci pneumonia prophylaxis prescribed (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"4280F","display":"Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count or percentage (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"4290F","display":"Patient screened for injection drug use (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"4293F","display":"Patient screened for high-risk sexual behavior (hiv)"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"86689","display":"Confirmation test for antibody to Human T-cell lymphotropic virus (HTLV) or HIV"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"86701","display":"Analysis for antibody to HIV -1 virus"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"86702","display":"Analysis for antibody to HIV-2 virus"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"86703","display":"Analysis for antibody to HIV-1 and HIV-2 virus"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87389","display":"Detection test by immunoassay technique for HIV-1 antigen and HIV-1 and HIV-2 antibodies"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87390","display":"Detection test by immunoassay technique for HIV-1 antigen"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87391","display":"Detection test by immunoassay technique for HIV-2 antigen"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87534","display":"Detection test by nucleic acid for HIV-1 virus, direct probe technique"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87535","display":"Detection test by nucleic acid for HIV-1 virus, amplified probe technique"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87536","display":"Detection test by nucleic acid for HIV-1 virus, quantification"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87537","display":"Detection test by nucleic acid for HIV-2 virus, direct probe technique"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87538","display":"Detection test by nucleic acid for HIV-2 virus, amplified probe technique"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87539","display":"Detection test by nucleic acid for HIV-2 virus, quantification"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87900","display":"Infectious agent drug susceptibility analysis"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87901","display":"Analysis test by nucleic acid for HIV-1 virus"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87903","display":"Analysis test by nucleic acid for HIV-1 virus, first through 10 drugs tested"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87904","display":"Analysis test by nucleic acid for HIV-1 virus, each additional drug tested"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"87906","display":"Analysis test by nucleic acid for HIV-1 virus, other region"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G0432","display":"Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G0433","display":"Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G0435","display":"Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"S3645","display":"Hiv-1 antibody testing of oral mucosal transudate"}]}}